11 August 2022 · Lidocaine products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
11 August 2022 · Rituximab products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
11 August 2022 · Diamorphine products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
11 August 2022 · Hydromorphone products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
11 August 2022 · Gentamicin products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
11 August 2022 · Omnipaque products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
11 August 2022 · Colistimethate products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
11 August 2022 · Topotecan products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
11 August 2022 · Fluorescein products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
11 August 2022 · Hydrocortisone acetate products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration